ALEXANDRIA, Va., Oct. 21 -- United States Patent no. RE50,631, issued on Oct. 14, was assigned to VelosBio Inc..
"ROR1 antibody immunoconjugates" was invented by Brian Lannutti (Solana Beach, Calif.), Katti Jessen (San Diego), Thanh-Trang Vo (San Diego) and Jeffry Dean Watkins (Encinitas, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are immunoconjugates comprising an anti-ROR-1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR-1 expressing cancers."
The patent was filed on July 1, 2021, under Application No. 17/365,293.
*For further information, including images, charts and tables, please visit: http://patft.uspto...